Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection;Vergleich von FDG und FDG-markierter leuko -zyten-PET/CT für die diagnose von infektionen

NuklearMedizin

Volumn 54, Issue 6, 2015, Pages 262-271

  Yilmaz, Sabire ^a   Aliyev, A ^b   Ekmekcioglu, O ^b   Ozhan, M ^b   Uslu, L ^b   Vatankulu, B ^b   Sager, S ^b   Halac M ^b   Sonmezoglu K ^b  

^a Ankara Ataturk Research and Training Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

FDG labeled leukocyte PET CT; Infection

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; AORTITIS; ARTICLE; BACTERIAL ARTHRITIS; BREAST CANCER; CELL VIABILITY; CHEMOTAXIS ASSAY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIABETIC FOOT; ENDOCARDITIS; FEMALE; GRAFT INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION; ISOTOPE LABELING; KNEE ARTHRITIS; LUNG LESION; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC IMPLANT; OSTEOMYELITIS; PROSPECTIVE STUDY; PROSTHESIS INFECTION; PYREXIA IDIOPATHICA; VERY ELDERLY; BACTERIAL INFECTIONS; COMPUTER ASSISTED TOMOGRAPHY; IMAGE ENHANCEMENT; LEUKOCYTE; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STAINING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; LEUKOCYTES; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84948990872     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/Nukmed-0724-15-02     Document Type: Article

References (35)

1. Aksoy SY, Asa S, Ozhan M et al. FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection. Eur J Nucl Med Mol Imaging 2014; 41: 556–564.
2. Basu S, Zhuang H, Torigian DA et al. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med 2009; 39: 124–145.
3. Bleeker-Rovers CP, de Kleijn E, Corstens FHM et al. Clinical value of FDG-PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004; 31: 29–37.
4. Chen SH, Ho KC, Hsieh PH et al. Potential clinical role of 18F FDG-PET/CT in detecting hip prosthesis infection: a study in patients undergoing twostage revision arthroplasty with an interim spacer. Q J Nucl Med Mol Imaging 2010; 54: 429–435.
5. Dumarey N, Egrise D, Blocklet D et al. Imaging infection with 18F-FDG-labeled leukocyte PET/ CT: initial experience in 21 patients. J Nucl Med 2006; 47: 625–632.
6. Fidel JV, Donnelly JP, Oyenb WJG et al. 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation. Eur J Nucl Med Mol Imaging 2012; 39: 120–128.
7. Forstrom LA, Dunn WL, Mullan BP et al. Biodistribution and dosimetry of [18F]fluorodeoxy -glucose labelled leukocytes in normal human subjects. Nucl Med Commun 2002; 23: 721–725.
8. Forstrom LA, Dunn WL, Rowe FA, Camilleri M. 111In-oxine-labelled granulocyte dosimetry in normal subjects. Nucl Med Commun 1995; 16: 349–356.
9. Forstrom LA, Mullan BP Hung JC et al. 18F-FDG labelling of human leukocytes. Nucl Med Commun 2000; 21: 691–694.
10. Jamar F, Buscombe J, Chitiet A et al. EANM/ SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med 2013; 54: 647–658.
11. Jones HA, Schofield JB, Krausz T et al. Pulmonary fibrosis correlates with duration of tissue neutrophil activation. Am J Respir Crit Care Med 1998; 158: 620–628.
12. Keidar Z, Militianu D, Melamed E et al. The diabetic foot: Initial experience with 18F-FDG-PET/ CT. J Nucl Med 2005; 46: 444–449.
13. Kim EE, Pjura GA, Lowry PA et al. Osteomyelitis complicating fracture: pitfalls of 111In leukocyte scintigraphy. AJR Am J Roentgenol 1987; 148: 927–930.
14. King AD, Peters AM, Stuttle AW, Lavender JP. Imaging of bone infection with labelled white blood cells: role of contemporaneous bone marrow imaging. Eur J Nucl Med 1990; 17: 148–151.
15. Kjaer A, Lebech AM, Eigtved A, Hojgaard L. Fever of unknown origin:prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004; 31: 622–626.
16. Lafont P, Morelec I, Fraysse M et al. 18F-FDG labeled leukocytes in vitro functional tests: viability, chemotaxis and phagocytosis assays. Open Nucl Med J 2011; 3: 25–29.
17. McAfee JG, Samin A. In-111 labeled leukocytes: a review of problems in image interpretation. Radiology 1985; 155: 221–229.
18. Osman S, Danpur HJ. The use of 2-[18F] fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 1992; 19: 183–190.
19. Palestro CJ, Kim CK, Swyer AJ et al. Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection. J Nucl Med 1990; 31: 1950–1955.
20. Palestro CJ, Love C. Decreased sensitivity of 18F-fluorodeoxyglucose imaging in infection and inflammation. Semin Nucl Med 2012; 42: 261–266.
21. Palestro CJ, Swyer AJ, Kim CK, Goldsmith SJ. Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging. Radiology 1991; 179: 645–648.
22. Pellegrino D, Bonab AA, Dragotakes SC et al. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med 2005; 46: 1522–1530.
23. Pio BS, Byrne FR, Aranda R et al. Non invasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]-fluoro-D-glucose labelled white blood cells. Mol Imaging Biol 2003; 5: 271–277.
24. Pring DJ, Henderson RG, Keshavarzian A et al. Indium-granulocyte scanning in the painful prosthetic joint. AJR Am J Roentgenol 1986; 147: 167–172.
25. Rini JN, Bhargava KK, Tronco GG et al. PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection. Radiology 2006; 238: 978–987.
26. Rüther W, Hotze A, Möller F et al. Diagnosis of bone and joint infection by leucocyte scintigraphy. A comparative study with 99mTc-HMPAO-labelled leucocytes, 99mTc-labelled antigranulocyte antibodies and 99mTc-labelled nanocolloid. Arch Orthop Trauma Surg 1990; 110: 26–32.
27. Saguwara Y, Braun DK, Kison PV et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron-emission tomography: Preliminary results. Eur J Nucl Med 1998; 25: 1238–1243.
28. Schauwecker DS. Osteomyelitis: diagnosis with In-111 labeled leukocytes. Radiology 1989; 171: 141–146.
29. Stumpe KD, Notzli HP, Zanetti M et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: Comparison with conventional radiography and three-phase bone scintigraphy. Radiology 2004; 231: 333–341.
30. Uno K, Matsui N, Nohira K et al. Indium-111 leukocyte imaging in patients with rheumatoid arthritis. J Nucl Med 1986; 27: 339–344.
31. Van Nostrand D, Abreu SH, Callaghan JJ et al. In-111-labeled white blood cell uptake in noninfected closed fracture in humans: prospective study. Radiology 1988; 167: 495–498.
32. Ward PA, Lentsch AB. The acute inflammatory response and its regulation. Arch Surg 1999; 134: 666–669.
33. Whalen JL, Brown ML, McLeod R, Fitzgerald RH Jr. Limitations of indium leukocyte imaging for the diagnosis of spine infections. Spine (Phila Pa 1976) 1991; 16: 193–197.
34. Zhuang HA. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002; 32: 47–59.
35. Zhuang HM, Cortes-Blanco A, Pourdehnad M et al. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun 2001; 22: 1123–1128.